These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6995308)

  • 21. Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli.
    Koplow J; Goldfine H
    J Bacteriol; 1974 Feb; 117(2):527-43. PubMed ID: 4590475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles.
    Roche A; McFadden J; Owen P
    Microbiology (Reading); 2001 Jan; 147(Pt 1):161-9. PubMed ID: 11160810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New major outer membrane proteins found in an Escherichia coli tolF mutant resistant to bacteriophage TuIb.
    Foulds J; Chai TJ
    J Bacteriol; 1978 Mar; 133(3):1478-83. PubMed ID: 346577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence plasmid-associated sensitivity to acid in Escherichia coli and its possible significance in human infections.
    Cooper GE; Rowbury RJ
    J Med Microbiol; 1986 Nov; 22(3):231-6. PubMed ID: 3534274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcin PDI Inhibits Antibiotic-Resistant Strains of Escherichia coli and
    Lu SY; Graça T; Avillan JJ; Zhao Z; Call DR
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30902857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermoregulation-dependent expression of Yersinia enterocolitica protein 1 imparts serum resistance to Escherichia coli K-12.
    Martinez RJ
    J Bacteriol; 1989 Jul; 171(7):3732-9. PubMed ID: 2661534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum.
    Taylor PW; Messner P; Parton R
    J Med Microbiol; 1981 Feb; 14(1):9-19. PubMed ID: 7007647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of outer membrane fragments from wild-type Escherichia coli and from several E. coli lipopolysaccharide mutants by EDTA and heat shock treatments.
    Marvin HJ; ter Beest MB; Witholt B
    J Bacteriol; 1989 Oct; 171(10):5262-7. PubMed ID: 2507517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli.
    Falchi FA; Maccagni EA; Puccio S; Peano C; De Castro C; Palmigiano A; Garozzo D; Martorana AM; Polissi A; Dehò G; Sperandeo P
    J Bacteriol; 2018 Jan; 200(2):. PubMed ID: 29109183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a new globomycin-resistant dnaE mutant of Escherichia coli.
    Sakka K; Watanabe T; Beers R; Wu HC
    J Bacteriol; 1987 Aug; 169(8):3400-8. PubMed ID: 3112119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92.
    Suerbaum S; Friedrich S; Leying H; Opferkuch W
    Zentralbl Bakteriol; 1994 Aug; 281(2):146-57. PubMed ID: 7858342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective transport and other phenotypes of a periplasmic "leaky" mutant of Escherichia coli K-12.
    Anderson JJ; Wilson JM; Oxender DL
    J Bacteriol; 1979 Nov; 140(2):351-8. PubMed ID: 387731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1.
    Weiser JN; Gotschlich EC
    Infect Immun; 1991 Jul; 59(7):2252-8. PubMed ID: 1646768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing of an encapsulated strain of Escherichia coli by human serum.
    Taylor PW; Kroll HP
    Infect Immun; 1983 Jan; 39(1):122-31. PubMed ID: 6185430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Escherichia coli strains containing fad mutations plus a triple plasmid expression system to study the import of myristate, its activation by Saccharomyces cerevisiae acyl-CoA synthetase, and its utilization by S. cerevisiae myristoyl-CoA:protein N-myristoyltransferase.
    Knoll LJ; Gordon JI
    J Biol Chem; 1993 Feb; 268(6):4281-90. PubMed ID: 8440712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on serum resistance in Escherichia coli.
    Kubens BS; Opferkuch W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a Pasteurella haemolytica A1 mutant deficient in production of three membrane lipoproteins.
    Murphy GL; Whitworth LC; Confer AW; Gaskins JD; Pandher K; Dabo SM
    Am J Vet Res; 1998 Oct; 59(10):1275-80. PubMed ID: 9781461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of arginine- and tryptophan-rich cyclic hexapeptides with Escherichia coli membranes.
    Junkes C; Wessolowski A; Farnaud S; Evans RW; Good L; Bienert M; Dathe M
    J Pept Sci; 2008 Apr; 14(4):535-43. PubMed ID: 17985396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.